Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain

International Journal of Antimicrobial Agents

Volumn 13, Issue 2, 1999, Pages 137-140

  Portillo, A ^a   Lantero, M ^b   Gastanares M J ^b   Ruiz Larrea, F ^a   Torres, C ^a  

^a UNIVERSITY OF LA RIOJA   (Spain)

^b HOSPITAL SAN PEDRO   (Spain)

Author keywords

Macrolides; Mechanisms of resistance; Streptococcus pyogenes

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPAIN; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; DNA-BINDING PROTEINS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ERYTHROMYCIN; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SPAIN; STREPTOCOCCUS PYOGENES; TRANSCRIPTION FACTORS; VIRGINIAMYCIN;

EID: 0033213064     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00104-1     Document Type: Article

References (37)

1. Bisno A. Streptococcus pyogenes. Mandell G.L., Bennett J.E., Dolin R. Principles and Practice of Infectious Diseases. 1995;1786-1799 Churchill Livingstone, New York.
2. Leclercq R., Courvalin P. Mechanisms of resistance to macrolides and functionally related antibiotics. Bryskier A.J., Butzler J.P., Neu H.C., Tulkens P.M. Macrolides: Chemistry, Pharmacology and Clinical Uses. 1993;125-141 Arnette, Blackwell, Paris.
3. Seppälä H., Skurnik M., Soini H., Roberts M.C., Huovinen P. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents. Chemother. 42:1998;257-262.
4. Clancy J., Petitpas J., Dib-Hajj F. et al. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:1996;867-879.
5. Pérez-Trallero E., Marimón J.M., Montes M., Orden B., de Pablos M. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg. Infect. Dis. 5:1999;235-240.
6. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 9th Informational Supplement. NCCLS document M100-S9. Wayne, PA: National Committee for Clinical Laboratory Standards 1999.
7. Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. Clin Microbiol Infect 1996;2 (Suppl. 1):S47-S48.
8. Seppälä H., Nissinen A., Yu Q., Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:1993;885-891.
9. Arthur M., Molinas C., Mabilat C. PCR detection of erm erythromycin resistance genes by using degenerate oligonucleotide primers. Persing D.H., Smith T.F., Tenover F.C., White T.J. Diagnostic Molecular Microbiology. 1993;534-538 American Society for Microbiology, Washington DC.
10. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents. Chemother. 40:1996;2562-2566.
11. Kataja J., Seppälä H., Skurnik M., Sarkkinen H., Huovinen P. Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob. Agents Chemother. 42:1998;1493-1494.
12. Sutcliffe J., Tait-Kamradt A., Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1996;1817-1824.
13. Caparon M.G., Scott J.R. Genetic manipulation of pathogenic streptococci. Methods Enzymol. 204:1991;556-586.
14. Cornaglia G., Ligozzi M., Mazzariol A. et al. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin. Infect. Dis. 27(Suppl. 1):1998;S87-92.
15. Esposito S., Noviello S., Ianniello F., D'Errico G. Erythromycin resistance in group A beta hemolytic Streptococcus. Chemotherapy. 44:1998;385-390.
16. García-Bermejo I., Cacho J., Orden B., Alós J.I., Gómez-Garcés J.L. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. Antimicrob. Agents Chemother. 42:1998;989-990.
17. Muñoz Bellido J.L., García-Sáenz J.A., Alonso Manzanares M.A., Gutiérrez Zufiaurre M.N., García-Rodríguez J.A. Resistencia a los macrólidos en Streptococcus pyogenes. Rev. Esp. Quimioter. 11:1998;196-204.
18. Orden B., Pérez-Trallero E., Montes M., Martínez R. Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatr. Infect. Dis. J. 17:1998;470-473.
19. Pérez-Trallero E., Urbieta M., Montes M., Ayestaran I., Marimon J.M. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur. J. Clin. Microbiol. Infect. Dis. 16:1998;25-31.
20. Borzani M., De Luca M., Varotto F. A survey of susceptibility to erythromycin among Streptococcus pyogenes isolates in Italy. J. Antimicrob. Chemother. 40:1997;457-458.
21. Cocuzza C.E., Mattina R., Mazariol A. et al. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (north Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study. Microb. Drug Res. 3:1997;371-378.
22. Jebelean C, Watschinger R, Haditsch M, Binder L, Mittermayer H. Erythromycin resistance of Streptococcus pyogenes strains from upper Austria. 20th International Congress of Chemotherapy, Sidney, 1997; abstract no 4306.
23. Cornaglia G., Ligozzi M., Mazzariol A., Valentini M., Orefici G., Fontana R. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy 1993-1995. Emerg. Infect. Dis. 2:1996;339-342.
24. Hsueh P.R., Chen H.M., Huang A.H., Wu J.J. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 39:1995;2239-2242.
25. Seppälä H, Klaukka T, Lehtonen P, Nenonen E, Finnish Study Group for Antimicrobial Resistance, Huovinen P. Outpatients use of erythromycin: Link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995;21:1378-1385.
26. Seppälä H., Nissinen A., Jirvinen H. et al. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:1992;292-297.
27. Phillips G., Parratt D., Orange G.V., Harper I., McEwan H., Young N. Erythromycin-resistant Streptococcus pyogenes. J. Antimicrob. Chemother. 25:1990;723-724.
28. Stingemore N., Francis G.R., Toohey M., McGerchie D.B. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med. J. Aust. 150:1989;626-631.
29. Barry A.L., Fuchs P.C., Brown S.D. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J. Antimicrob. Chemother. 40:1997;139-140.
30. Barry A.L., Pfaller M.A., Fuchs P.C., Packer R.R. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:1994;2419-2425.
31. Coonan K.M., Kaplan E.L. In vitro susceptibility of recent north american group A streptococcal isolates to eleven oral antibiotics. Pediatr. Infect. Dis. 13:1994;630-635.
32. Colodner P, Sakran V, Keness Y, Raz R. Streptococcus pyogenes isolated susceptibility to three macrolides in the Jezreel Valley. 8th European Congress of Clinical Microbiology and Infectious Diseases, Lausanne, 1997, abstract no P1166.
33. Rudensky B., Isaacson M., Beck A., Greenfield J. Increase in frequency of serious group A streptococcal infections. Isr. J. Med. Sci. 28:1992;752-753.
34. Jasir A., Schalén C. Survey of macrolide resistance phenotypes in swedish clinical isolates of Streptococcus pyogenes. J. Antimicrob. Chemother. 41:1998;135-137.
35. Kataja J., Huovinen P., Muotiala A. et al. Clonal spread of group A Streptococcus with the new type of erythromycin resistance. J. Infect. Dis. 177:1998;786-789.
36. Kataja J, Huovinen P, Skurnik M, the finnish study group for antimicrobial resistance, Seppälä H. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob Agents Chemother 1999;43:48-52.
37. Yeung R, De Azavedo JCS, Low DE. Active efflux and a novel erm methylase are the predominant mechanisms of macrolide resistance in group A streptococcal strains isolated in Ontario, Canada. Abstracts of the 38th Annual ICAAC 1998; San Diego, California, p. 76.